10-Q Filing

IOVANCE BIOTHERAPEUTICS, INC. CIK: 1425205 Q1 2014

Filing Information

Form Type	10-Q
Accession Number	`0001354488-14-002559`
Period End Date	20140331
Filing Date	20140514
Fiscal Year	2014
Fiscal Period	Q1
XBRL Instance	gnpb-20140331.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 54 Income Statement 57 Cash Flow Statement 132 Stockholders Equity 7

Balance Sheet 54 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`Cash`	$19.67M	USD	Point-in-time
Property and equipment, accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$32.57K	USD	Point-in-time
Cash and cash equivalents	`Cash`	$17.94M	USD	Point-in-time
Property and equipment, accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$16.00K	USD	Point-in-time
Deposits	`PrepaidExpenseAndOtherAssetsCurrent`	$10.00K	USD	Point-in-time
Deposits	`PrepaidExpenseAndOtherAssetsCurrent`	$15.00K	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$114.09K	USD	Point-in-time
Preferred Stock Par Value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$158.72K	USD	Point-in-time
Preferred Stock Par Value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred Stock Authorized	`PreferredStockSharesAuthorized`	50.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$19.85M	USD	Point-in-time
Preferred Stock Authorized	`PreferredStockSharesAuthorized`	50.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$18.07M	USD	Point-in-time
Property and equipment, net of accumulated depreciation of $32,567 and $16,002	`PropertyPlantAndEquipmentNet`	$14.63K	USD	Point-in-time
Preferred Stock Issued	`PreferredStockSharesIssued`	13,300.00	shares	Point-in-time
Property and equipment, net of accumulated depreciation of $32,567 and $16,002	`PropertyPlantAndEquipmentNet`	$27.76K	USD	Point-in-time
Preferred Stock Issued	`PreferredStockSharesIssued`	17,000.00	shares	Point-in-time
Total assets	`Assets`	$18.08M	USD	Point-in-time
Preferred Stock Outstanding	`PreferredStockSharesOutstanding`	17,000.00	shares	Point-in-time
Total assets	`Assets`	$19.87M	USD	Point-in-time
Preferred Stock Outstanding	`PreferredStockSharesOutstanding`	13,300.00	shares	Point-in-time
Common Stock Par Value	`CommonStockParOrStatedValuePerShare`	-	USD	Point-in-time
Common Stock Par Value	`CommonStockParOrStatedValuePerShare`	-	USD	Point-in-time
Common Stock Shares Authorized	`CommonStockSharesAuthorized`	150.00M	shares	Point-in-time
Common Stock Shares Authorized	`CommonStockSharesAuthorized`	150.00M	shares	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$412.98K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$286.32K	USD	Point-in-time
Common Stock Shares Issued	`CommonStockSharesIssued`	20.02M	shares	Point-in-time
Accrued expenses	`InterestPayableCurrent`	$1.86M	USD	Point-in-time
Common Stock Shares Issued	`CommonStockSharesIssued`	22.09M	shares	Point-in-time
Accrued expenses	`InterestPayableCurrent`	$823.16K	USD	Point-in-time
Common Stock Shares Outstanding	`CommonStockSharesOutstanding`	22.09M	shares	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$1.11M	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$2.27M	USD	Point-in-time
Common Stock Shares Outstanding	`CommonStockSharesOutstanding`	20.02M	shares	Point-in-time
Accrued compensation payable in shares of stock	`AccruedCompensationPayableInSharesOfStock`	-	USD	Point-in-time
Accrued compensation payable in shares of stock	`AccruedCompensationPayableInSharesOfStock`	$167.06K	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 50,000,000 shares authorized, 13,300 shares and 17,000 shares issued and outstanding, respectively	`PreferredStockValue`	$13.00	USD	Point-in-time
Preferred stock, $0.001 par value; 50,000,000 shares authorized, 13,300 shares and 17,000 shares issued and outstanding, respectively	`PreferredStockValue`	$17.00	USD	Point-in-time
Common stock, $0.000041666 par value; 150,000,000 shares authorized, 22,092,958 and 20,023,958 shares issued and outstanding, respectively	`CommonStockValue`	$921.00	USD	Point-in-time
Common stock, $0.000041666 par value; 150,000,000 shares authorized, 22,092,958 and 20,023,958 shares issued and outstanding, respectively	`CommonStockValue`	$835.00	USD	Point-in-time
Common shares to be issued, 303,125 shares	`CommonSharesToBeIssuedWith12SecuredPromissoryNotes`	$245.15K	USD	Point-in-time
Common shares to be issued, 303,125 shares	`CommonSharesToBeIssuedWith12SecuredPromissoryNotes`	$245.15K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$83.35M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$81.88M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-66.79M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-64.53M	USD	Point-in-time
Total Stockholders' Deficiency	`StockholdersEquity`	$16.81M	USD	Point-in-time
Total Stockholders' Deficiency	`StockholdersEquity`	$17.60M	USD	Point-in-time
Total Liabilities and Stockholders' Deficiency	`LiabilitiesAndStockholdersEquity`	$19.87M	USD	Point-in-time
Total Liabilities and Stockholders' Deficiency	`LiabilitiesAndStockholdersEquity`	$18.08M	USD	Point-in-time

Income Statement 57 line items

Line Item	Tag	Value	Unit	Period
Revenues	`SalesRevenueGoodsNet`	-	USD	1 Quarter
Revenues	`SalesRevenueGoodsNet`	-	USD	1 Quarter
Revenues	`SalesRevenueGoodsNet`	-	USD	26 Qtrs
Share-Based Compensation	`ShareBasedCompensation`	$87.39K	USD	1 Quarter
Share-Based Compensation	`ShareBasedCompensation`	$11.21M	USD	26 Qtrs
Share-Based Compensation	`ShareBasedCompensation`	$1.07M	USD	1 Quarter
Operating expenses (including $1,070,707, $87,386 and $11,209,659 of non-cash share-based compensation costs)	`OperatingCostsAndExpenses`	$33.11M	USD	26 Qtrs
Operating expenses (including $1,070,707, $87,386 and $11,209,659 of non-cash share-based compensation costs)	`OperatingCostsAndExpenses`	$1.96M	USD	1 Quarter
Operating expenses (including $1,070,707, $87,386 and $11,209,659 of non-cash share-based compensation costs)	`OperatingCostsAndExpenses`	$434.91K	USD	1 Quarter
Cost of Lion transaction - related party	`CostOfLionTransaction`	-	USD	1 Quarter
Cost of Lion transaction - related party	`CostOfLionTransaction`	-	USD	1 Quarter
Cost of Lion transaction - related party	`CostOfLionTransaction`	$16.66M	USD	26 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$270.00K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$302.66K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$5.22M	USD	26 Qtrs
Impairment of intangible asset	`ImpairmentOfIntangibleAssetsExcludingGoodwill`	$160.04K	USD	26 Qtrs
Impairment of intangible asset	`ImpairmentOfIntangibleAssetsExcludingGoodwill`	-	USD	1 Quarter
Impairment of intangible asset	`ImpairmentOfIntangibleAssetsExcludingGoodwill`	-	USD	1 Quarter
Total costs and expenses	`OperatingExpenses`	$2.26M	USD	1 Quarter
Total costs and expenses	`OperatingExpenses`	$704.91K	USD	1 Quarter
Total costs and expenses	`OperatingExpenses`	$55.14M	USD	26 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-55.14M	USD	26 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-2.26M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-704.91K	USD	1 Quarter
Interest expense	`InterestExpense`	-	USD	1 Quarter
Interest expense	`InterestExpense`	$2.52M	USD	26 Qtrs
Interest expense	`InterestExpense`	$341.62K	USD	1 Quarter
Change in fair value of derivative liabilities	`DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet`	-	USD	1 Quarter
Change in fair value of derivative liabilities	`DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet`	-	USD	1 Quarter
Change in fair value of derivative liabilities	`DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet`	$10.00M	USD	26 Qtrs
Amortization of discount on convertible notes	`AmortizationOfDebtDiscountPremium`	-	USD	1 Quarter
Amortization of discount on convertible notes	`AmortizationOfDebtDiscountPremium`	-	USD	1 Quarter
Amortization of discount on convertible notes	`AmortizationOfDebtDiscountPremium`	$5.50M	USD	26 Qtrs
Cost to induce exchange transaction	`CostToInduceExchangeTransaction`	$2.30M	USD	26 Qtrs
Cost to induce exchange transaction	`CostToInduceExchangeTransaction`	-	USD	1 Quarter
Cost to induce exchange transaction	`CostToInduceExchangeTransaction`	-	USD	1 Quarter
Financing costs	`AmortizationOfFinancingCosts`	-	USD	1 Quarter
Financing costs	`AmortizationOfFinancingCosts`	$2.87M	USD	26 Qtrs
Financing costs	`AmortizationOfFinancingCosts`	-	USD	1 Quarter
Total other income (expense)	`OtherNonoperatingIncomeExpense`	$-3.18M	USD	26 Qtrs
Total other income (expense)	`OtherNonoperatingIncomeExpense`	$-341.62K	USD	1 Quarter
Total other income (expense)	`OtherNonoperatingIncomeExpense`	-	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-1.05M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-2.26M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-58.33M	USD	26 Qtrs
Deemed dividend related to beneficial conversion feature of convertible preferred stock	`OtherPreferredStockDividendsAndAdjustments`	-	USD	1 Quarter
Deemed dividend related to beneficial conversion feature of convertible preferred stock	`OtherPreferredStockDividendsAndAdjustments`	$8.46M	USD	26 Qtrs
Deemed dividend related to beneficial conversion feature of convertible preferred stock	`OtherPreferredStockDividendsAndAdjustments`	-	USD	1 Quarter
Net Loss Attributable to Common Stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-66.79M	USD	26 Qtrs
Net Loss Attributable to Common Stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-1.05M	USD	1 Quarter
Net Loss Attributable to Common Stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-2.26M	USD	1 Quarter
Net Loss Per Share, Basic and Diluted	`EarningsPerShareBasicAndDiluted`	-	USD	26 Qtrs
Net Loss Per Share, Basic and Diluted	`EarningsPerShareBasicAndDiluted`	$-0.11	USD	1 Quarter
Net Loss Per Share, Basic and Diluted	`EarningsPerShareBasicAndDiluted`	$-1.28	USD	1 Quarter
Weighted-Average Common Shares Outstanding, Basic and Diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	818,806.00	shares	1 Quarter
Weighted-Average Common Shares Outstanding, Basic and Diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	20.80M	shares	1 Quarter
Weighted-Average Common Shares Outstanding, Basic and Diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	-	shares	26 Qtrs

Cash Flow Statement 132 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-1.05M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.26M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-58.33M	USD	26 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$1.96K	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$93.94K	USD	26 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$16.57K	USD	1 Quarter
Impairment of intangible asset	`ImpairmentOfIntangibleAssetsExcludingGoodwill`	$160.04K	USD	26 Qtrs
Impairment of intangible asset	`ImpairmentOfIntangibleAssetsExcludingGoodwill`	-	USD	1 Quarter
Impairment of intangible asset	`ImpairmentOfIntangibleAssetsExcludingGoodwill`	-	USD	1 Quarter
Fair value of vested stock options and warrants	`StockOptionPlanExpense`	$901.65K	USD	1 Quarter
Fair value of vested stock options and warrants	`StockOptionPlanExpense`	$6.09M	USD	26 Qtrs
Fair value of vested stock options and warrants	`StockOptionPlanExpense`	$87.39K	USD	1 Quarter
Fair value of common stock and warrants accounted for as financing costs	`FairValueOfCommonStockAndWarrantsAccountedForAsFinancingCosts`	-	USD	1 Quarter
Fair value of common stock and warrants accounted for as financing costs	`FairValueOfCommonStockAndWarrantsAccountedForAsFinancingCosts`	-	USD	1 Quarter
Fair value of common stock and warrants accounted for as financing costs	`FairValueOfCommonStockAndWarrantsAccountedForAsFinancingCosts`	$2.99M	USD	26 Qtrs
Fair value of vested warrants granted for services	`FairValueOfVestedWarrantsGrantedForServices`	-	USD	1 Quarter
Fair value of vested warrants granted for services	`FairValueOfVestedWarrantsGrantedForServices`	-	USD	1 Quarter
Fair value of vested warrants granted for services	`FairValueOfVestedWarrantsGrantedForServices`	$2.56M	USD	26 Qtrs
Amortization of discount on convertible notes	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-5.00M	USD	26 Qtrs
Amortization of discount on convertible notes	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	-	USD	1 Quarter
Amortization of discount on convertible notes	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	-	USD	1 Quarter
Private placement costs	`PrivatePlacementCosts1`	-	USD	1 Quarter
Private placement costs	`PrivatePlacementCosts1`	-	USD	1 Quarter
Private placement costs	`PrivatePlacementCosts1`	$385.00K	USD	26 Qtrs
Change in fair value of derivative liabilities	`DerivativeGainLossOnDerivativeNet`	-	USD	1 Quarter
Change in fair value of derivative liabilities	`DerivativeGainLossOnDerivativeNet`	$10.00M	USD	26 Qtrs
Change in fair value of derivative liabilities	`DerivativeGainLossOnDerivativeNet`	-	USD	1 Quarter
Common stock issued to officer for services	`CommonStockIssuedToOfficerForServices`	-	USD	1 Quarter
Common stock issued to officer for services	`CommonStockIssuedToOfficerForServices`	-	USD	1 Quarter
Common stock issued to officer for services	`CommonStockIssuedToOfficerForServices`	$8.01M	USD	26 Qtrs
Common stock issued for services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$17.70K	USD	1 Quarter
Common stock issued for services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$1.59M	USD	26 Qtrs
Common stock issued for services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	-	USD	1 Quarter
Common stock issued to induce conversion of warrants	`CommonStockIssuedToInduceConversionOfWarrants`	$122.73K	USD	26 Qtrs
Common stock issued to induce conversion of warrants	`CommonStockIssuedToInduceConversionOfWarrants`	-	USD	1 Quarter
Common stock issued to induce conversion of warrants	`CommonStockIssuedToInduceConversionOfWarrants`	-	USD	1 Quarter
Common stock issued to induce exchange transaction	`CommonStockIssuedToInduceExchangeTransaction`	$2.17M	USD	26 Qtrs
Common stock issued to induce exchange transaction	`CommonStockIssuedToInduceExchangeTransaction`	-	USD	1 Quarter
Common stock issued to induce exchange transaction	`CommonStockIssuedToInduceExchangeTransaction`	-	USD	1 Quarter
Common stock issued for Lion transaction	`CommonStockIssuedForLionTransaction`	-	USD	1 Quarter
Common stock issued for Lion transaction	`CommonStockIssuedForLionTransaction`	-	USD	1 Quarter
Common stock issued for Lion transaction	`CommonStockIssuedForLionTransaction`	$16.66M	USD	26 Qtrs
Common stock issued to directors	`CommonStockIssuedToDirectors`	-	USD	1 Quarter
Common stock issued to directors	`CommonStockIssuedToDirectors`	$2.00M	USD	26 Qtrs
Common stock issued to directors	`CommonStockIssuedToDirectors`	-	USD	1 Quarter
Fair value of common stock transferred to officer and director	`FairValueOfCommonStockTransferredToOfficerAndDirector`	$1.74M	USD	26 Qtrs
Fair value of common stock transferred to officer and director	`FairValueOfCommonStockTransferredToOfficerAndDirector`	-	USD	1 Quarter
Fair value of common stock transferred to officer and director	`FairValueOfCommonStockTransferredToOfficerAndDirector`	-	USD	1 Quarter
Write off of advances to related party	`WriteOffOfAdvancesToRelatedParty`	-	USD	1 Quarter
Write off of advances to related party	`WriteOffOfAdvancesToRelatedParty`	-	USD	1 Quarter
Write off of advances to related party	`WriteOffOfAdvancesToRelatedParty`	$50.00K	USD	26 Qtrs
Deposits, prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-124.09K	USD	26 Qtrs
Deposits, prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-875.00	USD	1 Quarter
Deposits, prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$49.62K	USD	1 Quarter
Accounts payable, accrued expenses and other current liabilities	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$-1.16M	USD	1 Quarter
Accounts payable, accrued expenses and other current liabilities	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$1.13M	USD	26 Qtrs
Accounts payable, accrued expenses and other current liabilities	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$316.45K	USD	1 Quarter
Accrued interest and penalty	`AccruedInterestAndPenalty`	$2.47M	USD	26 Qtrs
Accrued interest and penalty	`AccruedInterestAndPenalty`	-	USD	1 Quarter
Accrued interest and penalty	`AccruedInterestAndPenalty`	$341.62K	USD	1 Quarter
Accrued compensation payable in shares of common stock	`AccruedCompensationPayableInSharesOfCommonStock`	-	USD	1 Quarter
Accrued compensation payable in shares of common stock	`AccruedCompensationPayableInSharesOfCommonStock`	$167.06K	USD	1 Quarter
Accrued compensation payable in shares of common stock	`AccruedCompensationPayableInSharesOfCommonStock`	$167.06K	USD	26 Qtrs
Net Cash Used In Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$-2.27M	USD	1 Quarter
Net Cash Used In Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$-300.00K	USD	1 Quarter
Net Cash Used In Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$-15.05M	USD	26 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$51.19K	USD	26 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$3.44K	USD	1 Quarter
Advances to related party	`PaymentsToFundLongtermLoansToRelatedParties`	$50.00K	USD	26 Qtrs
Advances to related party	`PaymentsToFundLongtermLoansToRelatedParties`	-	USD	1 Quarter
Advances to related party	`PaymentsToFundLongtermLoansToRelatedParties`	-	USD	1 Quarter
Net Cash Used In Investing Activities	`NetCashProvidedByUsedInInvestingActivities`	$-101.19K	USD	26 Qtrs
Net Cash Used In Investing Activities	`NetCashProvidedByUsedInInvestingActivities`	$-3.44K	USD	1 Quarter
Net Cash Used In Investing Activities	`NetCashProvidedByUsedInInvestingActivities`	-	USD	1 Quarter
Proceeds from the issuance of convertible notes, net	`ProceedsFromConvertibleDebt`	-	USD	1 Quarter
Proceeds from the issuance of convertible notes, net	`ProceedsFromConvertibleDebt`	$4.93M	USD	26 Qtrs
Proceeds from the issuance of convertible notes, net	`ProceedsFromConvertibleDebt`	$300.00K	USD	1 Quarter
Proceeds from the issuance of secured promissory notes	`ProceedsFromIssuanceOfSecuredPromissoryNotesNet`	-	USD	1 Quarter
Proceeds from the issuance of secured promissory notes	`ProceedsFromIssuanceOfSecuredPromissoryNotesNet`	-	USD	1 Quarter
Proceeds from the issuance of secured promissory notes	`ProceedsFromIssuanceOfSecuredPromissoryNotesNet`	$1.48M	USD	26 Qtrs
Proceeds from issuance of common stock upon conversion of warrants	`ProceedsFromIssuanceOfCommonStockUponConversionOfWarrants`	$542.50K	USD	1 Quarter
Proceeds from issuance of common stock upon conversion of warrants	`ProceedsFromIssuanceOfCommonStockUponConversionOfWarrants`	-	USD	1 Quarter
Proceeds from issuance of common stock upon conversion of warrants	`ProceedsFromIssuanceOfCommonStockUponConversionOfWarrants`	$542.50K	USD	26 Qtrs
Proceeds from the issuance of common stock, net	`ProceedsFromIssuanceOfCommonStock`	$10.22M	USD	26 Qtrs
Proceeds from the issuance of common stock, net	`ProceedsFromIssuanceOfCommonStock`	-	USD	1 Quarter
Proceeds from the issuance of common stock, net	`ProceedsFromIssuanceOfCommonStock`	-	USD	1 Quarter
Proceeds from the issuance of preferred stock, net	`ProceedsFromIssuanceOfPreferredStockAndPreferenceStock`	$15.91M	USD	26 Qtrs
Proceeds from the issuance of preferred stock, net	`ProceedsFromIssuanceOfPreferredStockAndPreferenceStock`	-	USD	1 Quarter
Proceeds from the issuance of preferred stock, net	`ProceedsFromIssuanceOfPreferredStockAndPreferenceStock`	-	USD	1 Quarter
Due to director	`IncreaseDecreaseInDueToOfficersAndStockholders`	$18.14K	USD	26 Qtrs
Due to director	`IncreaseDecreaseInDueToOfficersAndStockholders`	-	USD	1 Quarter
Due to director	`IncreaseDecreaseInDueToOfficersAndStockholders`	-	USD	1 Quarter
Net Cash Provided By Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	$33.10M	USD	26 Qtrs
Net Cash Provided By Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	$542.50K	USD	1 Quarter
Net Cash Provided By Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	$300.00K	USD	1 Quarter
Net Increase (Decrease) In Cash And Cash Equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$17.94M	USD	26 Qtrs
Net Increase (Decrease) In Cash And Cash Equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-1.73M	USD	1 Quarter
Net Increase (Decrease) In Cash And Cash Equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	-	USD	1 Quarter
Cash and Cash Equivalents, Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$17.94M	USD	Point-in-time
Cash and Cash Equivalents, Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$19.67M	USD	Point-in-time
Cash and Cash Equivalents, Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time
Cash and Cash Equivalents, Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time
Cash and Cash Equivalents, Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time
Cash and Cash Equivalents, End of Period	`CashAndCashEquivalentsAtCarryingValue`	$17.94M	USD	Point-in-time
Cash and Cash Equivalents, End of Period	`CashAndCashEquivalentsAtCarryingValue`	$19.67M	USD	Point-in-time
Cash and Cash Equivalents, End of Period	`CashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time
Cash and Cash Equivalents, End of Period	`CashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time
Cash and Cash Equivalents, End of Period	`CashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time
Derivative liability recorded upon issuance of convertible notes and warrants	`DerivativeLiabilityRecordedUponIssuanceOfConvertibleNotesAndAttachedWarrants`	-	USD	1 Quarter
Derivative liability recorded upon issuance of convertible notes and warrants	`DerivativeLiabilityRecordedUponIssuanceOfConvertibleNotesAndAttachedWarrants`	$5.54M	USD	26 Qtrs
Derivative liability recorded upon issuance of convertible notes and warrants	`DerivativeLiabilityRecordedUponIssuanceOfConvertibleNotesAndAttachedWarrants`	-	USD	1 Quarter
Derivative liability recorded as offering cost	`DerivativeLiabilityRecordedAsPrivatePlacementCost`	-	USD	1 Quarter
Derivative liability recorded as offering cost	`DerivativeLiabilityRecordedAsPrivatePlacementCost`	$1.90M	USD	26 Qtrs
Derivative liability recorded as offering cost	`DerivativeLiabilityRecordedAsPrivatePlacementCost`	-	USD	1 Quarter
Common stock issued for intellectual property	`StockIssued1`	-	USD	1 Quarter
Common stock issued for intellectual property	`StockIssued1`	-	USD	1 Quarter
Common stock issued for intellectual property	`StockIssued1`	$217.41K	USD	26 Qtrs
Forgiveness of debt by director, treated as contribution of capital	`DebtInstrumentDecreaseForgiveness`	-	USD	1 Quarter
Forgiveness of debt by director, treated as contribution of capital	`DebtInstrumentDecreaseForgiveness`	-	USD	1 Quarter
Forgiveness of debt by director, treated as contribution of capital	`DebtInstrumentDecreaseForgiveness`	$18.14K	USD	26 Qtrs
Common stock issued upon conversion of convertible notes	`DebtConversionOriginalDebtAmount1`	$6.79M	USD	26 Qtrs
Common stock issued upon conversion of convertible notes	`DebtConversionOriginalDebtAmount1`	-	USD	1 Quarter
Common stock issued upon conversion of convertible notes	`DebtConversionOriginalDebtAmount1`	-	USD	1 Quarter
Fair value of common stock issued with notes payable recorded as a note discount	`FairValueOfCommonStockIssuedWithNotesPayableRecordedAsNoteDiscount`	-	USD	1 Quarter
Fair value of common stock issued with notes payable recorded as a note discount	`FairValueOfCommonStockIssuedWithNotesPayableRecordedAsNoteDiscount`	-	USD	1 Quarter
Fair value of common stock issued with notes payable recorded as a note discount	`FairValueOfCommonStockIssuedWithNotesPayableRecordedAsNoteDiscount`	$497.89K	USD	26 Qtrs
Settlement of accounts payable through issuance of common stock	`SettlementOfAccountsPayableThroughIssuanceOfCommonStock`	-	USD	1 Quarter
Settlement of accounts payable through issuance of common stock	`SettlementOfAccountsPayableThroughIssuanceOfCommonStock`	$25.00K	USD	26 Qtrs
Settlement of accounts payable through issuance of common stock	`SettlementOfAccountsPayableThroughIssuanceOfCommonStock`	-	USD	1 Quarter
Common stock issued upon conversion of accrued interest and penalty	`CommonStockIssuedUponConversionOfAccruedInterestAndPenalty`	-	USD	1 Quarter
Common stock issued upon conversion of accrued interest and penalty	`CommonStockIssuedUponConversionOfAccruedInterestAndPenalty`	$2.47M	USD	26 Qtrs
Common stock issued upon conversion of accrued interest and penalty	`CommonStockIssuedUponConversionOfAccruedInterestAndPenalty`	-	USD	1 Quarter

Stockholders Equity 7 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance, Amount	`StockholdersEquity`	$16.81M	USD	Point-in-time
Beginning Balance, Amount	`StockholdersEquity`	$17.60M	USD	Point-in-time
Common stock issued upon exercise of warrants, Amount	`CommonStockIssuedUponExerciseOfWarrantsAmount`	$542.49K	USD	1 Quarter
Fair value of vested stock options and warrants, Amount	`FairValueOfVestedStockOptionsAndWarrantsAmount`	$901.65K	USD	1 Quarter
Net loss	`ProfitLoss`	$-2.26M	USD	1 Quarter
Ending Balance, Amount	`StockholdersEquity`	$16.81M	USD	Point-in-time
Ending Balance, Amount	`StockholdersEquity`	$17.60M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.